Health
Study finds combination therapy suppresses pancreatic tumor growth in mice – Medical Xpress
UCLA Jonsson Comprehensive Cancer Center researchers have uncovered a potential new way to target pancreatic tumors that express high intratumoral interferon signaling…
UCLA Jonsson Comprehensive Cancer Center researchers have uncovered a potential new way to target pancreatic tumors that express high intratumoral interferon signaling (IFN). The team found that high type I IFN signaling is present in a subset of pancreatic tumors and it triggers a decrease in the level of NAD and NADH in pancreatic cancer cells, which are vital cofactors in critical metabolic processes.
After the researchers delineated the mechanism by which the NAD depletion occurs, they demonstrated…
-
General19 hours agoByford rail extension opening marks final stage of Perth Metronet
-
General21 hours agoMango the muster cat draws attention to western Queensland’s ongoing recovery
-
Business23 hours agoWhat $10,000 invested in the iShares S&P 500 IVV ETF could be in 10 years
-
Business21 hours agoTop brokers name 3 ASX shares to buy next week 12 October 2025